Complement Control Protein Modules in the Regulators of Complement Activation

Author(s):  
Paul Barlow ◽  
Dinesh Soares
1998 ◽  
Vol 35 (6-7) ◽  
pp. 384
Author(s):  
Joanne M. O'Leary ◽  
Nicholas P. Mullin ◽  
Robert Ramage ◽  
Paul N. Barlow

2019 ◽  
Vol 116 (20) ◽  
pp. 9953-9958 ◽  
Author(s):  
Hemendra Singh Panwar ◽  
Hina Ojha ◽  
Payel Ghosh ◽  
Sagar H. Barage ◽  
Sunil Raut ◽  
...  

The complement system is highly efficient in targeting pathogens, but lack of its apposite regulation results in host-cell damage, which is linked to diseases. Thus, complement activation is tightly regulated by a series of proteins, which primarily belong to the regulators of complement activation (RCA) family. Structurally, these proteins are composed of repeating complement control protein (CCP) domains where two to four successive domains contribute to the regulatory functions termed decay-accelerating activity (DAA) and cofactor activity (CFA). However, the precise constitution of the functional units and whether these units can be joined to form a larger composition with dual function have not been demonstrated. Herein, we have parsed the functional units for DAA and CFA by constructing chimeras of the decay-accelerating factor (DAF) that exhibits DAA and membrane cofactor protein (MCP) that exhibits CFA. We show that in a four-CCP framework, a functional unit for each of the regulatory activities is formed by only two successive CCPs wherein each participates in the function, albeit CCP2 has a bipartite function. Additionally, optimal activity requires C-terminal domains that enhance the avidity of the molecule for C3b/C4b. Furthermore, by composing a four-CCP DAF-MCP chimera with robust CFA (for C3b and C4b) and DAA (for classical and alternative pathway C3 convertases), named decay cofactor protein, we show that CCP functional units can be linked to design a dual-activity regulator. These data indicate that the regulatory determinants for these two biological processes are distinct and modular in nature.


2007 ◽  
Vol 81 (8) ◽  
pp. 4166-4176 ◽  
Author(s):  
Linda Mark ◽  
O. Brad Spiller ◽  
Marcin Okroj ◽  
Simon Chanas ◽  
Jim A. Aitken ◽  
...  

ABSTRACT The diversity of viral strategies to modulate complement activation indicates that this component of the immune system has significant antiviral potential. One example is the Kaposi's sarcoma-associated herpesvirus (KSHV) complement control protein (KCP), which inhibits progression of the complement cascade. Rhesus rhadinovirus (RRV), like KSHV, is a member of the subfamily Gammaherpesvirinae and currently provides the only in vivo model of KSHV pathobiology in primates. In the present study, we characterized the KCP homologue encoded by RRV, RRV complement control protein (RCP). Two strains of RRV have been sequenced to date (H26-95 and 17577), and the RCPs they encode differ substantially in structure: RCP from strain H26-95 has four complement control protein (CCP) domains, whereas RCP from strain 17577 has eight CCP domains. Transcriptional analyses of the RCP gene (ORF4, referred to herein as RCP) in infected rhesus macaque fibroblasts mapped the ends of the transcripts of both strains. They revealed that H26-95 encodes a full-length, unspliced RCP transcript, while 17577 RCP generates a full-length unspliced mRNA and two alternatively spliced transcripts. Western blotting confirmed that infected cells express RCP, and immune electron microscopy disclosed this protein on the surface of RRV virions. Functional studies of RCP encoded by both RRV strains revealed their ability to suppress complement activation by the classical (antibody-mediated) pathway. These data provide the foundation for studies into the biological significance of gammaherpesvirus complement regulatory proteins in a tractable, non-human primate model.


2008 ◽  
Vol 377 (3) ◽  
pp. 902-913 ◽  
Author(s):  
Agnès Le Saux ◽  
Patricia Miang Lon Ng ◽  
Joanne Jing Yun Koh ◽  
Diana Hooi Ping Low ◽  
Geraldine E-Ling Leong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document